High and Dry: Tackling Global Water Stress
Scroll to the top

mRNA: Unlocking the power of our body’s protein factory

Graphic text: What's next for mRNA?

While Pfizer is currently focused on developing mRNA vaccines to help prevent the flu and shingles and to treat rare diseases, it continues to explore other opportunities where the technology could make a transformational impact on patients, and where its expertise has the potential to accelerate the pace of innovation.

Learn more about mRNA at Pfizer.com.


Subscribe to GZERO's daily newsletter